Institutional investors purchased a net $722.7 thousand shares of ATHX during the quarter ended September 2016 and now own 16.96% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 10.0 Thousand shares of Athersys Inc
SIMPLEX TRADING LLC Sold 8.9 Thousand shares of Athersys Inc